Summary of Key Points
Chanel’s newly launched Reconstructed PDRN anti-aging product highlights “simulating the effects of a triple-layer hydrodermal therapy” and “project-level skin repair,” but existing scientific evidence does not fully support these claims. The article exposes issues such as incomplete experimental controls, confusion over the contributions of various ingredients, and discrepancies between experimental findings and promotional statements, urging consumers to be skeptical of the marketing rhetoric surrounding “topical cosmetic treatments.”
Detailed Analysis
1. Promising “hydrodermal effects” without direct comparison
The main benefits that attract consumers to hydrodermal therapies are collagen regeneration, skin elasticity, and anti-aging. However, Chanel’s experiments only compared their product with hydrodermal treatments in terms of anti-inflammation, ignoring the other key aspects. More critically, the brand did not compare their product with hydrodermal therapies in the context of collagen promotion; instead, they used “animal-derived PDRN” (without clarifying the source or production method). This is like claiming to be as fast as Liu Xiang but only comparing your heart rate during warm-up, which is irrelevant to actual running performance.
2. Inaccurate comparison of penetration technologies
The brand claims that their Reconstructed PDRN uses “EXOMIL milk nanoscale penetration technology,” allowing for faster absorption compared to animal-derived PDRN. The problem is that they are comparing a product with delivery technology with one that may or may not have such technology. It’s like comparing a person wearing professional running shoes with someone running barefoot; the winner doesn’t necessarily mean the former runs faster. A fair comparison would involve both products using (or not using) penetration technology to determine which absorbs better.
3. Blurring the role of PDRN and other ingredients
The promotion emphasizes that “reconstructed PDRN” promotes the growth of multiple types of collagen, but the fine print indicates that it’s actually “reconstructed type III collagen” that stimulates the production of types IV, VII, and XVII collagen. This suggests that PDRN is not the primary ingredient responsible for these effects.
4. Real-world experiments show a combination of treatments
The real-person experiments on the product page seem to suggest similar results to hydrodermal therapies, but the design compares “hydrodermal treatment + product” to “hydrodermal treatment alone.” The former shows better outcomes, indicating that the product enhances the effects of the treatment, not that it can mimic the therapy itself. A proper comparison would involve comparing the product’s effect when used alone with when no treatment is applied at all.
5. Limited applicability after medical procedures
Many influencers claim that this product can be used universally after medical treatments, but the fine print states that it should only be used after hydrodermal therapy and when the skin is ready for topical products (e.g., waiting a few days after a procedure). This broad claim exceeds the actual scope of validation.
Conclusion
“Topical cosmetic treatments” are a trend, but not all claims must be credible. When choosing such products, consumers should look beyond slogans like “simulating hydrodermal effects” and “revolutionary technology.” They should evaluate the experimental design and whether the evidence supports the claims. Good products should be backed by science, not marketing that tries to explain science.